Key statistics dashboard for Elutia Inc (ELUT). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women’s Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction.
Stock Data
| Price | $0.81 |
| Market Cap | $36M |
| Enterprise Value | $26.7M |
| Beta | 0.71 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | 0.61 |
| Price / Book | 2.22 |
| P/S | 2.91 |
| EV/EBITDA | -1.11 |
| EV/Sales | 2.20 |
| EV/FCF | -0.59 |
| P/FCF | -0.78 |
| Earnings Yield | 146.62% |
| FCF Yield | -127.00% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 57.82% |
| EBIT Margin | -212.90% |
| EBITDA Margin | -198.86% |
| Operating Margin | -194.03% |
| Net Margin | 426.93% |
| Return on Equity | 940.81% |
| Return on Assets | 118.69% |
| Return on Invested Capital | -79.27% |
| Return on Capital Employed | -104.16% |
Financial Health
| Current Ratio | 1.77 |
| Quick Ratio | 1.64 |
| Cash Ratio | 0.95 |
| Debt / Equity | 0.69 |
| Debt / Assets | 24.72% |
| Net Debt / EBITDA | 0.38 |
| Interest Coverage | 6.77 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -3.65 |
Per-Share Data
| Revenue per share | 0.28 |
| Book Value per share | 0.36 |
| Cash per share | 0.46 |
| FCF per share | -1.04 |
| Tangible Book Value per share | 0.34 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 5 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 5 |
| Avg rating (1-5) | 1.00 |
Related companies: ANVS · BCAB · CALC · CELU · LTRN · MAIA · PYPD
Explore sector: Healthcare · Biotechnology
More sections of ELUT: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks